Salarius Pharmaceuticals, Inc. Common Stock

SLRX XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

4.9M

Short interest (Dec 31)

3.8%

Net Short (Jan 07 ): 7.7%

Borrow Fee

309.16%

↓ 35.7%

Available Shares

50K

↑ 20.0%

Price Chart

Company Overview

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001615219

Asset Type: CS

Market Data

Market Cap: $4,924,229

Employees: 2

Status: Active

Short Interest

Current Borrow Fee 309.16%

Range: 308.84% - 353.00%

Available Shares 50K

Range: 0 - 100K

Recent Changes

Fee Change: ↓ 5.9%

Available Change: ↓ 12.1%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime